-
Your selected country is
Australia
- Change country/language
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
HLA-B7-PE
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
HLA-B7 is a monoclonal antibody designed for flow cytometry (FC) use as a direct immunofluorescence reagent in the identification and enumeration of HLA-B7 antigen-expressing cells.HLA-B7 monoclonal antibody binds to the HLA-B7 antigen and does not cross react with HLAB27 or other related HLA antigens. HLAB27 and HLA-B7 antigens are expressed in 7% and 22% of individuals of Caucasian origin. This mixture of antibodies permits the characterization of HLAB27 specificity in the HLA class I allotype in patients suffering from inflammatory disorders affecting the sacroiliac and intervertebral joints. HLAB27-PE antibody can be used to distinguish true HLA-B27 positives (HLA-B27+/HLA-B7-) from false HLA-B27 positives (HLA-B7dim+/HLA-B7+).
No Citations are available for this Product
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.
Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.